Treatment of diabetic rats with encapsulated islets

Immunoprotection of islets using bioisolator systems permits introduction of allogeneic cells to diabetic patients without the need for immunosuppression. Using TheraCyte™ immunoisolation devices, we investigated two rat models of type 1 diabetes mellitus (T1DM), BB rats and rats made diabetic by st...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweet, Ian R, Yanay, Ofer, Waldron, Lanaya, Gilbert, Merle, Fuller, Jessica M, Tupling, Terry, Lernmark, Ake, Osborne, William R A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828880/
https://www.ncbi.nlm.nih.gov/pubmed/18373735
http://dx.doi.org/10.1111/j.1582-4934.2008.00322.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828880/
https://www.ncbi.nlm.nih.gov/pubmed/18373735
http://dx.doi.org/10.1111/j.1582-4934.2008.00322.x

Ejemplares similares